Thomas Lavery focuses on complex patent litigation, primarily in the pharmaceutical, biotechnology, and chemical arts. His experience includes representing pharmaceutical companies in high-stakes patent litigations involving a broad range of therapeutic areas and technologies—from pharmaceutical compounds and formulations for the treatment of schizophrenia, multiple sclerosis, and osteoporosis, to drug packaging and synthetic processes.

Before joining Kenyon & Kenyon, Mr. Lavery served as a legal fellow for the Creative Commons and Science Commons where he worked on making scientific data and databases more freely available. And before attending law school, Mr. Lavery conducted genomic research and wrote bioinformatics software as part of the Human Genome Project at the Whitehead Institute. While working for the Human Genome Project, he took software engineering classes at the Harvard University Extension School.

Mr. Lavery received his B.S. in Biochemistry from Tufts University, and his J.D. from Cornell University Law School, where he served as editor for both the Cornell Law Review and Legal Information Institute and received an award for excellence in legal research